Detalles de la búsqueda
1.
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Clin Chem
; 69(9): 1050-1061, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477541
2.
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
Clin Epigenetics
; 15(1): 112, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415208
3.
CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
J Immunother
; 45(7): 324-334, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862127
4.
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
Clin Epigenetics
; 14(1): 50, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35410311
5.
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival.
J Immunother
; 45(4): 194-206, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34908008
6.
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head and neck squamous cell carcinoma.
Epigenomics
; 13(2): 113-127, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351665
7.
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
EBioMedicine
; 59: 102962, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861198
8.
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.
Clin Epigenetics
; 11(1): 161, 2019 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747929
9.
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
EBioMedicine
; 48: 341-352, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628024
10.
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.
JCI Insight
; 3(13)2018 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29997292
11.
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Oncoimmunology
; 7(8): e1452579, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221045
12.
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
PLoS One
; 13(2): e0192742, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29425237
13.
PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
Oncotarget
; 9(1): 641-650, 2018 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29416641
Resultados
1 -
13
de 13
1
Próxima >
>>